Schedule 13G ownership disclosure

ACORDA THERAPEUTICS INC

Security class unavailable · CUSIP: 00484M601

Event date: 2020-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
641,178
Percent of class
8.0200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001623632-21-000183
Form type
SC 13G
Filer
Acorda Therapeutics, Inc.
CIK
CIK 1008848
Filed
Feb 10, 2021
Reporting period
Dec 31, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub